Michael R Bates

This inventor holds 20 USPTO granted patents, plus 2 CIPO patents and 7 EPO patents. Top assignees: Grape Technology Group, Inc., Laboratory Corporation of America Holdings, Monogram Biosciences, Inc.. Active years: 1991-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael R Bates. Retrieved from https://idiyas.com/inventor/michael-r-bates-lc9lnxfc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20

% Patents Active = 40.0

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 7 (Patent Applications = 2)

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 144(Granted Patents)

Location History:

New Haven, IL (US) (1991)
Worthington, OH (US) (2009 - 2014)
Bethlehem, PA (US) (2011 - 2014)
San Carlos, CA (US) (2013 - 2023)

Company Filing History:

10 out of 70

Grape Technology Group, Inc.

patents

5 out of 127

Laboratory Corporation of America Holdings

patents

1 out of 52

Monogram Biosciences, Inc.

patents

4. 4 out of 834,513

Other

patents

Years Active: 1991-2023

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11579148 - Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients (2023-02-14),

2. 11401344 - Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients (2022-08-02),

3. 10775382 - Methods of determining patient response by measurement of HER-3 (2020-09-15),

4. 10416162 - Her2 diagnostic methods (2019-09-17),

5. 9766242 - Methods of determining patient response by measurement of HER-3 and P95 (2017-09-19),

6. 9110066 - HER-3 antibodies and methods of use (2015-08-18),

7. 8774780 - System and method for providing mobile device services using SMS communications (2014-07-08),

8. 8700024 - System and method for enhanced directory assistance including commercial features (2014-04-15),

9. 8699692 - System and method for processing and routing incoming calls to a communication assistance system (2014-04-15),

10. 8526596 - Cross-protocol universal call identifier (2013-09-03),

11. 8526594 - System and method for improved directory assistance including re-dial feature (2013-09-03),

12. 8412169 - System and method for providing mobile device services using SMS communications (2013-04-02),

13. 8349574 - Methods of determining patient response by measurement of Her-3 (2013-01-08),

14. 8335307 - System and method for improved directory assistance including re-dial feature (2012-12-18),

15. 8325904 - System and method for facilitating privacy in directory assistance communications (2012-12-04),

Title: Michael R. Bates: Innovator in Cancer Metastasis Research

Introduction

Michael R. Bates, a notable inventor based in New Haven, IL, has made significant strides in the field of oncology through his innovative research and inventions. With a remarkable portfolio of 20 patents, Bates has contributed valuable methods that aim to improve the lives of cancer patients by enhancing the accuracy of survival predictions and metastasis assessments.

Latest Patents

Among his latest patents, Bates focuses on groundbreaking methods for determining the likelihood of survival and predicting the likelihood of metastasis in cancer patients. His inventions specifically relate to methods of accurately quantifying HER2 and/or p95 expression in subjects with HER2 positive cancer, which are critical for indicating the risk of brain relapse in such patients. This pivotal research addresses pressing issues in personalized medicine, helping to provide patients with tailored treatment options.

Career Highlights

Throughout his career, Michael R. Bates has worked with reputable companies including Grape Technology Group, Inc. and Laboratory Corporation of America Holdings. His experiences in these organizations have bolstered his expertise in the biological sciences and technology applications in healthcare, enabling him to develop innovative solutions for pressing medical challenges.

Collaborations

Bates has collaborated with esteemed colleagues such as Faith McGary and Christine Baumeister. These partnerships have been instrumental in promoting interdisciplinary approaches to research, further enhancing the quality and impact of their innovative developments.

Conclusion

Michael R. Bates stands out as a leading inventor in the field of cancer research. His dedication to advancing medical technology and improving patient outcomes through his patented innovations marks him as a significant contributor to the ongoing fight against cancer. With continuous advancements in his research, Bates remains a key figure in the innovation landscape of oncology.

Profile summary based on public USPTO records.